MarketReportsOnline.com adds "Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)" report to its research store.

Pune, Maharashtra -- (SBWire) -- 12/17/2016 --The report entitled "Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)", provides an analysis of global biosimilar market in terms of value. The report also provides a brief analysis of the global biologics market by value and market share by products.

Complete report on Biosimilars market spread across 58 pages providing 4 company profiles and 11 tables and 17 figures is now available at http://www.marketreportsonline.com/contacts/purchase.php?name=540889.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biosimilar market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Sandoz, Amgen, Celltrion and Pfizer are some of the key players operating in the global biosimilar market whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies of the companies.

Company Coverage
- Sandoz
- Amgen
- Celltrion
- Pfizer

Majority of biosimilars are in pipeline as most of the major biologics have either already expired or are about to lose their patent in the next two years which act as a major driving force for the biosimilar market. Four major biologics namely Humira, Enbrel, Remicade and Infliximab patents are set to expire in December 2016, incentivizes a large number of companies to enter into biosimilar market.

The biosimilar market is in its early stages, but is expected to grow in the next five years. The global biosimilar market is supported by various growth drivers such as growing pressure to curtail healthcare expenditure, patent expiries of major biopharmaceuticals, rising chronic disease among aging population and positive outcomes in ongoing clinical trials etc. Yet the market faces some challenges, such as restrict entry of new players, the complexity of manufacturing biosimilars and clinical limitations including patient recruitment obstacles.

Complete report available at http://www.marketreportsonline.com/540889.html.

Few Points from List of Tables & Figures:
Table 1: Chemical Drugs Vs 1st Generation Biologics Vs 2nd Generation Biologics
Figure 1: Biologics Manufacturing Method
Table 2: Top 5 Biologics Drugs
Table 3: US Approved Biosimilars
Table 4: Biosimilars Vs Generics
Figure 2: Global Pharmaceutical Market by Value; 2015-2020E (US$ Billion)
Figure 3: Global Pharmaceutical Sales- Biotech Vs Conventional Technology;2010-2015
Figure 4: Global Biologics Market by Value; 2010-2015 (US$ Billion)
Figure 5: Global Biologics Market by Value; 2016-2020E (US$ Billion)
Figure 6: Global Biologics Market Share by Products; 2015
Figure 7: Global Biosimilar Market by Value; 2015-2020E (US$ Billion)
Table 5: Biosimilars in the Pipeline
Figure 8: Global Health Expenditure (% of Total GDP); 2010-2014
Table 6: Leading Biologic Products with Patent Expiries; 2014-2020

Other Related Reports on Biosimilar Market:

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis (http://www.marketreportsonline.com/504244.html) The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soaring healthcare costs globally.

Global Biosimilar Market Trends & Opportunities (http://www.marketreportsonline.com/395635.html) Rising budgetary pressures to reduce healthcare expenditures, patent expiries of blockbuster drugs, growing demand for cost-effective alternatives, increasing aging population, conductive government initiatives and rising incidences of various diseases are significant factors that are responsible for the growth of global biosimilar market (2013 to 2018). On the other hand stringent regulatory environment in some countries, high manufacturing complexities, costs, and presence of low priced generic drugs and high-entry barriers are considered to hinder the market growth.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com